Breakthroughs in Genitourinary Cancers – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The 2024 European Society for Medical Oncology Congress in Barcelona, ESMO 2024, served as a pivotal platform for unveiling breakthroughs and addressing ongoing challenges in Genitourinary Cancers. This white paper dives deep into the transformative potential of…
Read more
Breakthroughs in Prostate Cancer – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The 2024 European Society for Medical Oncology Congress in Barcelona, ESMO 2024, served as a pivotal platform for unveiling breakthroughs and addressing ongoing challenges in prostate cancer care and research. Prostate cancer took center stage, with sessions…
Read more
Free Live Online Masterclass RWE & Trials with Professor Stuart Pocock THE VALUE OF HIERARCHICAL COMPOSTE ENDPOINTS AND THE WIN RATIO: Experience in Clinical Trials and extension to Real World DATE: Wednesday, 22 January 2025, at 5pm CEST | 4pm UK time | 11am EST. Join Professor Stuart Pocock—one of the world’s leading experts in…
Read more
‘Unlocking Success: Mastering your RWE Pregnancy Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Wednesday, 12 February 2025 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Helen Dolk Professor of Epidemiology and Health Services Research at Ulster University. REGISTER HERE Real-world evidence (RWE) plays…
Read more
Breakthroughs in Lung & Other Thoracic Cancers – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The 2024 European Society for Medical Oncology Congress in Barcelona, ESMO 2024, provided a pivotal venue for showcasing breakthroughs and addressing persistent challenges in cancer care and research. Non-metastatic non-small cell lung cancer (NSCLC)…
Read more
OXON Epidemiology at the 21st Global CVCT Forum December 9-11, 2024 | Washington, DC OXON Epidemiology will be participating in the 21st Global CardioVascular Clinical Trialists Forum (CVCT), taking place in Washington, DC, from December 9 to December 11, 2024. This prestigious forum brings together global leaders in cardiovascular research, regulatory authorities, and industry experts…
Read more
Breakthroughs in Upper Gastrointestinal Tumours – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. Upper gastrointestinal (GI) tumours, including hepatocellular carcinoma (HCC), gastric cancer, and esophageal cancer, were a major focus at ESMO 2024, with sessions dedicated to advancing therapeutic strategies, improving patient outcomes, and addressing quality-of-life concerns. This white…
Read more
OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE. OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical…
Read more
Breakthroughs in Breast Cancer – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. Early-stage breast cancer, among the most frequently diagnosed cancers globally, was a key focus at this year’s ESMO conference, with sessions dedicated to advancing novel therapeutic strategies, improving personalized treatment approaches, and tackling survivorship challenges. “Breakthroughs in Breast…
Read more
Breakthroughs in Melanoma – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The advancements in melanoma therapies presented at this year’s ESMO conference mark a transformative shift in the treatment landscape, with Real-World Evidence (RWE) playing a pivotal role in personalizing patient care. By integrating real-world data with clinical trial…
Read more
